Indian Army Medical Injectables Tender Jammu & Kashmir 2026 – Injectable Drugs & Reagents, Est. ₹42,549, No Specifications

Tender Overview

Organization: Indian Army (Department Of Military Affairs) – Location: JAMMU, JAMMU & KASHMIR - 180001. Product/Service: injectable medicines and reagents including Noradrenaline Injection, Diazepam 10 mg/2 ml, Propofol 1%/10 mg 20 ml vial, Glutaraldehyde benzylalkonium chloride 100 g, Bupivacaine HCl 5 mg/20 ml, Calcium gluconate 10% 10 ml, Vasopressin 20 units/ml, Paraformaldehyde tablets, Methylene Blue 100 ml, Vecuronium Bromide 4 mg/1 ml, Phenylephrine 10 mg/1 ml. Estimated Value: ₹42,549. BOQ shows 10 items with unspecified quantities. Tender features a quantity option clause for up to 25% variation. No product-specific standards listed. Unique risk: lack of explicit technical specs requires bidders to rely on standard pharmaceutical procurement practices and ensure GMP/ISO alignment where applicable. The tender focuses on supply of multiple injectable drugs and reagents within government medical logistics.

Technical Specifications & Requirements

• No explicit technical specifications are provided in the tender data.
• Listed items cover a broad range of injectable drugs and chemical reagents: Noradrenaline, Diazepam, Propofol, Glutaraldehyde/Benzylalkonium chloride, Bupivacaine, Calcium gluconate, Vasopressin, Paraformaldehyde, Methylene Blue, Vecuronium, Phenylephrine.
• 10 items in the BOQ with unspecified quantities; no delivery metrics, packaging, or batch requirements stated.
• Option Clause allows up to 25% quantity increase/decrease at contract award and during currency, with delivery timing calculated as (Additional quantity / Original quantity) × Original delivery period, minimum 30 days. If original period is shorter, extend to original period.
• No explicit standards (IS/ISO) or packaging requirements are specified in the tender data; bidders should prepare documentation for standard GMP/compliance as per national procurement norms.

Terms, Conditions & Eligibility

• EMD: Not specified in the provided data; verify bid document for exact security requirements.
• Delivery Terms: Delivery period terms exist as a mechanism for option clause; actual delivery dates not disclosed.
• Payment Terms: Not detailed in the tender; bidders should seek clarification in the bid submission.
• Documents: No explicit document list beyond typical tender submissions; ensure GST, PAN, and GMP/compliance certificates are prepared per standard government medical procurements.
• Warranty/Penalties: No penalty or warranty terms provided in the data; confirm in final tender documents.
• Eligibility: No explicit year/turnover criteria stated; bidders should meet standard pharmaceutical supplier prerequisites and certificate requirements.